Patent Technology: Transfer and Industrial CompetitionNova Science Publishers, 2007 - 162 lappuses The pace of US Technologies advancement is crucial to the US economy and its growth. Productivity and international competitiveness are important contributing factors. This book presents important analyses on patents, technology transfer and industrial competitiveness. |
No grāmatas satura
1.–3. rezultāts no 48.
53. lappuse
... drug without fear of civil or criminal liability , an enterprise must both obtain FDA approval and consider whether that drug has been patented . Often the entity which owns the patent on a pharmaceutical is the first to be awarded ...
... drug without fear of civil or criminal liability , an enterprise must both obtain FDA approval and consider whether that drug has been patented . Often the entity which owns the patent on a pharmaceutical is the first to be awarded ...
63. lappuse
... drugs ] ( measured two years after entry ) . " [ 189 ] The 1984 Act created mechanisms to address concerns that regulatory requirements for FDA approval of a drug prior to marketing often meant that the owner of a patent associated with a ...
... drugs ] ( measured two years after entry ) . " [ 189 ] The 1984 Act created mechanisms to address concerns that regulatory requirements for FDA approval of a drug prior to marketing often meant that the owner of a patent associated with a ...
97. lappuse
... drug research and development operations . The Hatch - Waxman Act is widely credited with encouraging and expediting the creation and availability of generic versions of approved patented drugs . Prior to its enactment , pharmaceutical ...
... drug research and development operations . The Hatch - Waxman Act is widely credited with encouraging and expediting the creation and availability of generic versions of approved patented drugs . Prior to its enactment , pharmaceutical ...
Citi izdevumi - Skatīt visu
Patent Technology: Transfer and Industrial Competition Juanita M. Branes Ierobežota priekšskatīšana - 2007 |
Bieži izmantoti vārdi un frāzes
104th Congress Act P.L. activities additional Advanced Technology Program agencies Aimster amended approved drug awards basic research Bayh-Dole Act Bolar brand name budget claims commercialization companies compound Congress contributory cooperative research copyright infringement CRADA CRS Report defense efforts encourage facilitate Federal Circuit federal funding federal laboratories file-sharing filing date financing firms first-inventor-to-file granted Grokster Hatch-Waxman Act increase inequitable conduct innovation Integra Intellectual Property inventor issue Journal license litigation mandated Manufacturing Extension Partnership Manufacturing Technology market exclusivity marketplace Merck KGaA million for ATP Napster National noninfringing obtain Patent Act patent application patent expiration patent infringement patent law patent protection patent rights patent system patented invention pharmaceutical industry preclinical prior user rights private sector requirement rescission research and development result safe harbor Senate tax credit technological advancement technology development technology transfer U.S. patent U.S. Supreme Court United universities USPTO